Deciphering Clonal Hematopoiesis of Indeterminate Potential: Methods, Mechanisms, and Implications for Kidney...

Area of Science:

• Nephrology
• Hematology
• Genetics

Background:

• Chronic kidney disease (CKD) affects over 10% of US adults, with prevalence increasing with age.
• Clonal hematopoiesis of indeterminate potential (CHIP) is an age-related blood disorder driven by somatic mutations, increasing risk for hematologic malignancy and cardiovascular disease.
• Emerging evidence links CHIP to kidney outcomes, including CKD and AKI, independent of traditional risk factors.

Purpose of the Study:

• To review current observations and hypotheses linking CHIP and kidney disease.
• To highlight the need for research into CHIP's role in CKD pathogenesis and comorbidities.
• To explore the potential of anti-inflammatory treatments for CHIP-associated kidney disease.

Main Methods:

• This is a review article, synthesizing existing epidemiological, cell-based, and murine studies.
• It discusses proposed hypotheses and observational data linking CHIP to kidney outcomes.
• It considers the heterogeneity of CKD and CHIP in its analysis.

Main Results:

• CHIP is independently associated with increased risk for CKD and AKI.
• The exact mechanisms by which CHIP contributes to kidney disease remain to be fully elucidated.
• CHIP may be a causal factor or a marker of aging and comorbidity in kidney disease.

Conclusions:

• CHIP is increasingly recognized as a significant factor in kidney disease development and progression.
• Further research is crucial to define the causal relationship and underlying pathways between CHIP and kidney disease.
• Targeting inflammation may offer a therapeutic strategy for CHIP-associated kidney conditions.